Dr. Julia Rosebush is a pediatric infectious diseases specialist at the University of Chicago, Comer Children's Hospital. A native Midwesterner, she grew up in Michigan, pursuing her undergraduate studies in Psychology at the Michigan State University Honors College and then attending medical school at the Michigan State University College of Osteopathic Medicine where she graduated in 2006. Dr. Rosebush completed her pediatrics residency training at Nationwide Children's Hospital/The Ohio State University in 2009, before taking a position in the Baylor International Pediatric AIDS Initiative (BIPAI) in Gaborone Botswana, where she played an integral role in the scale-up of antiretroviral therapy for HIV-positive youth throughout the country. It was there that she discovered her passion for HIV medicine and returned to the United States to pursue an infectious diseases fellowship at Emory University in Atlanta, GA. She joined the University of Chicago faculty in the Section of Pediatric Infectious Diseases in 2014.
Dr. Rosebush currently serves as the Medical Director of Care2Prevent (C2P), the University’s Pediatric and Adolescent HIV Program, the largest provider of pediatric HIV care in South Chicago. Under her leadership, the program has steadily expanded to provide comprehensive biomedical care, supportive services, and prevention efforts to South Chicago’s most vulnerable youth. She and her team are steadily working to increase the routine, opt-out HIV screening of adolescents in emergency room settings, network recruitment for HIV/STI testing in high prevalence neighborhoods, and the uptake of HIV pre-exposure prophylaxis (PrEP) for HIV-1 prevention. Dr. Rosebush’s primary interests focus on HIV-1 specifically as it relates to the management of multidrug resistant infections, STI co-infection, and the biopsychosocial aspects of prevention. She serves as site PI for a number of protocols within the PHACS and IMPAACT networks of the NIH.
Outside of the HIV realm, Dr. Rosebush is highly involved with medical education both clinically and administratively as Program Director for the Pediatric Infectious Diseases training program with a particular interest in leadership development amongst trainees. A MERITS scholar from 2018-2019, she is currently working on the design and implementation of a leadership curriculum targeted toward pediatric subspecialty fellows to better equip them in their future careers.
Dr. Rosebush and her husband live in the Old Town neighborhood of Chicago with their young daughter and are passionate international travelers and photographers with the goal of eating their way across the entire globe.
Emory University School of Medicine
Atlanta, GA
- Pediatric Infectious Diseases Fellowship
2014
Nationwide Children's Hospital/The Ohio State University
Columbus, OH
- Pediatrics Residency
2009
Michigan State University College of Osteopathic Medicine
East Lansing, MI
DO - Doctor of Osteopathy
2006
Michigan State University Honors College
East Lansing, MI
BS - Psychology/Health and Humanities
2001
Hyperferritinemia: A Diagnostic Marker for Disseminated Neonatal Herpes Simplex Virus Infection?
Hyperferritinemia: A Diagnostic Marker for Disseminated Neonatal Herpes Simplex Virus Infection? Pediatr Ann. 2021 Jun; 50(6):e264-e267.
PMID: 34115559
Pharmacokinetics and safety of maraviroc in neonates.
Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021 03 01; 35(3):419-427.
PMID: 33252481
Pharmacokinetics and safety of maraviroc in neonates.
Rosebush JC, Best BM, Chadwick EG, Butler K, Moye J, Smith E, Bradford S, Reding CA, Mathiba SR, Hanley S, Aziz M, Homans J, Acosta EP, Murtaugh W, Vourvahis M, Mcfadyen L, Hayward K, Mirochnick M, Samson P. Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2020 Nov 26.
PMID: 33252481
COVID-19 pneumonia in an infant with a hemodynamically significant ventricular septal defect.
COVID-19 pneumonia in an infant with a hemodynamically significant ventricular septal defect. Cardiol Young. 2021 Jan; 31(1):138-140.
PMID: 33040743
Corrigendum to: 2269. HIV-Positive Individuals Who Report Being in Care Are Less Likely to Be Co-Infected With an STI; an Analysis of "Network Testing," A Service Program Offering HIV and STI Testing Services to Individual at Risk for HIV.
Corrigendum to: 2269. HIV-Positive Individuals Who Report Being in Care Are Less Likely to Be Co-Infected With an STI; an Analysis of "Network Testing," A Service Program Offering HIV and STI Testing Services to Individual at Risk for HIV. Open Forum Infect Dis. 2020 Jun; 7(6):ofz147.
PMID: 32665954
From Infancy to Adolescence: Infectious Disease Pearls for the Pediatric Provider.
From Infancy to Adolescence: Infectious Disease Pearls for the Pediatric Provider. Pediatr Ann. 2019 Sep 01; 48(9):e341-e342.
PMID: 31505006
2269. HIV-Positive Individuals Who Report Being in Care Are Less Likely to Be Co-Infected With an STI; an Analysis of "Network Testing," A Service Program Offering HIV and STI Testing Services to Individual at Risk for HIV.
2269. HIV-Positive Individuals Who Report Being in Care Are Less Likely to Be Co-Infected With an STI; an Analysis of "Network Testing," A Service Program Offering HIV and STI Testing Services to Individual at Risk for HIV. Open Forum Infect Dis. 2018 Nov 26; 5(suppl_1):S671-S672.
PMID: 31421051
Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth.
Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther. 2018; 23(4):315-324.
PMID: 28994661
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth.
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):539-546.
PMID: 28902705
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth.
Eckard AR, O'Riordan MA, Rosebush JC, Ruff JH, Chahroudi A, Labbato D, Daniels JE, Uribe-Leitz M, Tangpricha V, McComsey GA. Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth. . 2017 12 15; 76(5):539-546.
PMID: 28902705
The Lucille Lester Award for Promotion of Childhood Wellness
The University of Chicago
2018
Medical Education Research, Innovation, Teaching and Scholarship (MERITS) Scholar
The University of Chicago
2018 - 2019
Richard M. Rothberg Faculty Award for Excellece in Patient Care and Resident Education
The University of Chicago
2016
Young Investigator Award
Conference on Retroviruses and Opportunistic Infections (CROI)
2014
First Place, Fellows Teaching Competition
Emory University School of Medicine
2013
Emory Global Health Residency Scholar
Emory University
2012 - 2013